Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 216

1.

Brustkrebs-Patientinnen brauchen auch Ihre Unterstützung!

Harbeck N, Mahner S.

MMW Fortschr Med. 2019 Aug;161(14):42. doi: 10.1007/s15006-019-0782-3. Review. German. No abstract available.

PMID:
31414432
2.

[Breast cancer in young women].

Burgmann DM, Dobler F, Zeder-Göss C, Mahner S, Harbeck N, Würstlein R.

MMW Fortschr Med. 2019 Aug;161(14):43-47. doi: 10.1007/s15006-019-0783-2. Review. German. No abstract available.

PMID:
31414431
3.

[Breast cancer - a modern approach in oncoplastic surgery].

Hagemann F, Geiger P, Luczak C, Perabò M, Degenhardt T, Schenck T, Mahner S, Harbeck N, Ditsch N.

MMW Fortschr Med. 2019 Aug;161(14):47-50. doi: 10.1007/s15006-019-0784-1. Review. German. No abstract available.

PMID:
31414430
4.

Final results from GCIG/ENGOT/AGO-OVAR 12, a randomised placebo-controlled phase III trial of nintedanib combined with chemotherapy for newly diagnosed advanced ovarian cancer.

Ray-Coquard I, Cibula D, Mirza MR, Reuss A, Ricci C, Colombo N, Koch H, Goffin F, González-Martin A, Ottevanger PB, Baumann K, Bjørge L, Lesoin A, Burges A, Rosenberg P, Gropp-Meier M, Harrela M, Harter P, Frenel JS, Minarik T, Pisano C, Hasenburg A, Merger M, du Bois A; AGO Study Group-led GCIG/ENGOT Intergroup Consortium.

Int J Cancer. 2019 Aug 5. doi: 10.1002/ijc.32606. [Epub ahead of print]

PMID:
31381147
5.

Factors associated with the decline of psychological support in hospitalized patients with cancer.

Pichler T, Dinkel A, Marten-Mittag B, Hermelink K, Telzerow E, Ackermann U, Belka C, Combs SE, Gratzke C, Gschwend J, Harbeck N, Heinemann V, Herkommer K, Kiechle M, Mahner S, Pigorsch S, Rauch J, Stief C, Beckmann J, Heußner P, Herschbach P.

Psychooncology. 2019 Aug 1. doi: 10.1002/pon.5191. [Epub ahead of print]

PMID:
31368613
6.

Predicting the course of disease in recurrent vulvar cancer - A subset analysis of the AGO-CaRE-1 study.

Woelber L, Eulenburg C, Kosse J, Neuser P, Heiss C, Hantschmann P, Mallmann P, Tanner B, Pfisterer J, Jückstock J, Hilpert F, de Gregorio N, Iborra S, Sehouli J, Ignatov A, Hillemanns P, Fürst S, Strauss HG, Mahner S, Prieske K; AGO-CaRE 1 investigators.

Gynecol Oncol. 2019 Jul 16. pii: S0090-8258(19)31395-2. doi: 10.1016/j.ygyno.2019.07.009. [Epub ahead of print]

PMID:
31324454
7.

The Formation and Therapeutic Update of Tumor-Associated Macrophages in Cervical Cancer.

Wang Q, Steger A, Mahner S, Jeschke U, Heidegger H.

Int J Mol Sci. 2019 Jul 5;20(13). pii: E3310. doi: 10.3390/ijms20133310. Review.

8.

Extracapsular Lymph Node Involvement in Ovarian Carcinoma.

Heublein S, Schulz H, Marmé F, Angele M, Czogalla B, Burges A, Mahner S, Mayr D, Jeschke U, Schmoeckel E.

Cancers (Basel). 2019 Jul 1;11(7). pii: E924. doi: 10.3390/cancers11070924.

9.

Predictive factors for lymph node metastases in vulvar cancer. An analysis of the AGO-CaRE-1 multicenter study.

Klapdor R, Wölber L, Hanker L, Schmalfeldt B, Canzler U, Fehm T, Luyten A, Hellriegel M, Kosse J, Heiss C, Hantschmann P, Mallmann P, Tanner B, Pfisterer J, Jückstock J, Hilpert F, de Gregorio N, Hillemanns P, Fürst ST, Mahner S.

Gynecol Oncol. 2019 Jun 18. pii: S0090-8258(19)31324-1. doi: 10.1016/j.ygyno.2019.06.013. [Epub ahead of print]

PMID:
31227222
10.

Correlation of the Aryl Hydrocarbon Receptor with FSHR in Ovarian Cancer Patients.

Deuster E, Mayr D, Hester A, Kolben T, Zeder-Göß C, Burges A, Mahner S, Jeschke U, Trillsch F, Czogalla B.

Int J Mol Sci. 2019 Jun 12;20(12). pii: E2862. doi: 10.3390/ijms20122862.

11.

Niraparib Maintenance Therapy in Patients With Recurrent Ovarian Cancer After a Partial Response to the Last Platinum-Based Chemotherapy in the ENGOT-OV16/NOVA Trial.

Del Campo JM, Matulonis UA, Malander S, Provencher D, Mahner S, Follana P, Waters J, Berek JS, Woie K, Oza AM, Canzler U, Gil-Martin M, Lesoin A, Monk BJ, Lund B, Gilbert L, Wenham RM, Benigno B, Arora S, Hazard SJ, Mirza MR.

J Clin Oncol. 2019 Jun 7:JCO1802238. doi: 10.1200/JCO.18.02238. [Epub ahead of print]

PMID:
31173551
12.

Glucocorticoid receptors α and β are modulated sex specifically in human placentas of intrauterine growth restriction (IUGR).

Hutter S, Hepp P, Hofmann S, Kuhn C, Messner J, Andergassen U, Mayr D, Emilia Solano M, Obermeier V, Mahner S, Arck P, Jeschke U.

Arch Gynecol Obstet. 2019 Aug;300(2):323-335. doi: 10.1007/s00404-019-05189-7. Epub 2019 May 14.

PMID:
31089804
13.

Interrelations of Sphingolipid and Lysophosphatidate Signaling with Immune System in Ovarian Cancer.

Meshcheryakova A, Svoboda M, Jaritz M, Mungenast F, Salzmann M, Pils D, Cacsire Castillo-Tong D, Hager G, Wolf A, Braicu EI, Sehouli J, Lambrechts S, Vergote I, Mahner S, Birner P, Zimmermann P, Brindley DN, Heinze G, Zeillinger R, Mechtcheriakova D.

Comput Struct Biotechnol J. 2019 Apr 10;17:537-560. doi: 10.1016/j.csbj.2019.04.004. eCollection 2019.

14.

A randomized trial comparing limited-excision conisation to Large Loop Excision of the Transformation Zone (LLETZ) in cervical dysplasia patients.

Kolben TM, Etzel LT, Bergauer F, Hagemann I, Hillemanns P, Repper M, Kaufmann AM, Sotlar K, Kolben T, Helms HJ, Gallwas J, Mahner S, Dannecker C.

J Gynecol Oncol. 2019 May;30(3):e42. doi: 10.3802/jgo.2019.30.e42.

15.

Thyronamine regulation of TAAR1 expression in breast cancer cells and investigation of its influence on viability and migration.

Tremmel E, Hofmann S, Kuhn C, Heidegger H, Heublein S, Hermelink K, Wuerstlein R, Harbeck N, Mayr D, Mahner S, Ditsch N, Jeschke U, Vattai A.

Breast Cancer (Dove Med Press). 2019 Feb 19;11:87-97. doi: 10.2147/BCTT.S178721. eCollection 2019.

16.

Liver rupture in a 28-year-old primigravida with superimposed pre-eclampsia and hemolysis, elevated liver enzyme levels, and low platelet count syndrome.

Kaltofen T, Grabmeier J, Weissenbacher T, Hallfeldt K, Mahner S, Hutter S.

J Obstet Gynaecol Res. 2019 May;45(5):1066-1070. doi: 10.1111/jog.13941. Epub 2019 Mar 10.

PMID:
30854740
17.

Anti α-enolase antibody is a novel autoimmune biomarker for unexplained recurrent miscarriages.

Ye Y, Kuhn C, Kösters M, Arnold GJ, Ishikawa-Ankerhold H, Schulz C, Rogenhofer N, Thaler CJ, Mahner S, Fröhlich T, Jeschke U, von Schönfeldt V.

EBioMedicine. 2019 Mar;41:610-622. doi: 10.1016/j.ebiom.2019.02.027. Epub 2019 Mar 1.

18.

The Prognostic Impact of the Aryl Hydrocarbon Receptor (AhR) in Primary Breast Cancer Depends on the Lymph Node Status.

Jeschke U, Zhang X, Kuhn C, Jalaguier S, Colinge J, Pfender K, Mayr D, Ditsch N, Harbeck N, Mahner S, Sixou S, Cavaillès V.

Int J Mol Sci. 2019 Feb 26;20(5). pii: E1016. doi: 10.3390/ijms20051016.

19.

A Randomized Trial of Lymphadenectomy in Patients with Advanced Ovarian Neoplasms.

Harter P, Sehouli J, Lorusso D, Reuss A, Vergote I, Marth C, Kim JW, Raspagliesi F, Lampe B, Aletti G, Meier W, Cibula D, Mustea A, Mahner S, Runnebaum IB, Schmalfeldt B, Burges A, Kimmig R, Scambia G, Greggi S, Hilpert F, Hasenburg A, Hillemanns P, Giorda G, von Leffern I, Schade-Brittinger C, Wagner U, du Bois A.

N Engl J Med. 2019 Feb 28;380(9):822-832. doi: 10.1056/NEJMoa1808424.

PMID:
30811909
20.

Vascular endothelial growth factor receptor 2 (VEGFR2) correlates with long-term survival in patients with advanced high-grade serous ovarian cancer (HGSOC): a study from the Tumor Bank Ovarian Cancer (TOC) Consortium.

Guan J, Darb-Esfahani S, Richter R, Taube ET, Ruscito I, Mahner S, Woelber L, Prieske K, Concin N, Vergote I, Van Nieuwenhuysen E, Achimas-Cadariu P, Glajzer J, Woopen H, Stanske M, Kulbe H, Denkert C, Sehouli J, Braicu EI.

J Cancer Res Clin Oncol. 2019 Apr;145(4):1063-1073. doi: 10.1007/s00432-019-02877-4. Epub 2019 Feb 27.

PMID:
30810838

Supplemental Content

Loading ...
Support Center